Research Title:
Understanding the Mortality Risk of Metabolic Syndrome Using UK Biobank
Research Question:
Which component(s) of metabolic syndrome confer the highest risk for all-cause and cause-specific mortality?
Aims and Objectives:
To treat metabolic syndrome as a unified clinical condition rather than separate diseases.
To quantify the individual and combined contributions of obesity, hypertension, dyslipidemia, and insulin resistance to long-term mortality.
To assess whether modeling metabolic syndrome as a composite improves mortality risk prediction compared to evaluating each component separately.
To inform risk stratification strategies for earlier intervention and improved clinical outcomes.
Scientific Rationale:
Metabolic syndrome is a common and growing health problem globally, associated with increased risk of type 2 diabetes, heart disease, liver disease, and premature death. Despite their shared metabolic roots, the components of metabolic syndrome are usually managed independently by different specialists. This fragmented approach may miss patients at the highest risk. By using UK Biobank data to study these components together and over time, we aim to understand better how these interrelated conditions interact to influence mortality risk, and which features should be prioritized for prevention.